Delivery Order SPE2DB20D1102-SPE2DB25FC6HE
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,898.65 Delivery Order contract is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a Firm Fixed Price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a Defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,880.76 and an ultimate completion date of November 14, 2023. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $12,876.63, is a delivery order with a firm fixed price. The period of performance extends to August 9, 2024. This contract is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 mg tablets in quantities of 120 per container. The contract has a ceiling value of $17,368.57 and spans from the award date of September 25, 2024 through the ultimate completion date of September 26, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,317.10 firm-fixed-price delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $7,049.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of June 17, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.72 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, with a completion date of May 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $7,500.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of July 3, 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of CONTRAVE ER 8/90MG 120, a prescription pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price of $28,603.83 and a completion date of September 4, 2024. It is a delivery order contract with no set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,720.09, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of June 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...